التفاصيل البيبلوغرافية
| العنوان: |
Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis |
| المؤلفون: |
Pemmaraju, Naveen *, Carter, Bing Z., Bose, Prithviraj, Jain, Nitin, Kadia, Tapan M., Garcia-Manero, Guillermo, Bueso-Ramos, Carlos E., DiNardo, Courtney D., Bledsoe, Sharon, Daver, Naval G., Popat, Uday, Konopleva, Marina Y., Zhou, Lingsha, Pierce, Sherry, Estrov, Zeev E., Borthakur, Gautam M., Ohanian, Maro, Qiao, Wei, Masarova, Lucia, Wang, Xuemei, Mak, Po Yee, Cortes, Jorge, Jabbour, Elias, Verstovsek, Srdan |
| المصدر: |
In Blood Advances 24 August 2021 5(16):3163-3173 |
| قاعدة البيانات: |
ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder